Pipeline

Japan

Development stage Development code
(generic name)
dosage form
Remarks Therapeutic category Indications In-house/
licensed
Approval AK-156
(zoledronic acid)
injection
New indication, new dose, once-yearly administration Bisphosphonate Osteoporosis Licensed
Regulatory review MN-10-T
(teriparatide acetate)
injection
New dose, extension of duration Osteoporosis drug Osteoporosis with high risk of fracture In-house
Phase 3 ART-123
(thrombomodulin alfa)
injection
Additional indication Anticoagulant Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) In-house
Phase 2 ART-123
(thrombomodulin alfa)
injection
Additional indication Anticoagulant Chemotherapy-
induced peripheral neuropathy (CIPN)
In-house

Outside Japan

Development stage Development code
(generic name)
dosage form
Remarks Therapeutic category Indications In-house/
licensed
Phase 3 ART-123
(thrombomodulin alfa)
injection
New biologic Anticoagulant Severe sepsis with coagulopathy In-house
HE-69
(mizoribine)
Additional indication Immunosuppressant Lupus nephritis, nephrotic syndrome In-house
Page Top